MichaelBouvetMD
General Surgery • La Jolla, CAEndocrine, Pancreas, Surgical Oncology (Other than Breast)
Surgical Oncology and Endocrine Surgery at UCSD
Dr. Bouvet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
UCSD Moores Cancer Center
La Jolla, CA 92093Phone+1 858-822-6191Fax+1 858-249-0483
Summary
- Dr. Michael Bouvet is a general surgeon in La Jolla, CA and is affiliated with multiple hospitals in the area, including Rady Children's Hospital - San Diego, UC San Diego Health, and VA San Diego Healthcare System. He received his medical degree from University of Washington School of Medicine and has been in practice 28 years. He specializes in endocrine, pancreas, and surgical oncology (other than breast) and is experienced in endocrine surgery, esophageal surgery, surgical oncology (non-breast), thyroid surgery, and parathyroid surgery.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1998
University of California (San Diego) Medical CenterResidency, Surgery, 1995
University of Washington School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1990 - 2026
TX State Medical License 1995 - 1999- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2010-2013
- Join now to see all
Clinical Trials
- A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery Start of enrollment: 2020 Jun 18
- ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery Start of enrollment: 2022 Apr 29
Publications & Presentations
PubMed
- Selective Synergy of Recombinant Methioninase Plus Docetaxel Against Docetaxel-resistant and -sensitive Fibrosarcoma Cells Compared to Normal Fibroblasts.Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Michael Bouvet
Anticancer Research. 2024-12-01 - Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells.Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung M Kang, Michael Bouvet
Anticancer Research. 2024-11-01 - Accurate and Safe Tumor Targeting of Orally-administeredA1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice.Sei Morinaga, Ming Zhao, Kohei Mizuta, Byung Mo Kang, Motokazu Sato
In Vivo. 2024-10-30
Press Mentions
- San Diego’s Top Doctors 2020: The ListOctober 28th, 2020
Anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule Antibody for Fluorescence VisualizationJanuary 31st, 2020
Guiding Lights: UC San Diego Launches Center for Fluorescence-Guided SurgeryDecember 5th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
